APA (7th ed.) Citation

BM, S., ML, F., KE, H., C, Z., A, N., J, M., . . . AJ, S. (2026). Revisiting Survival in the Treatment of Spinal Metastases From Lung Cancer in the Modern Era of Immunotherapy and Molecular Targeted Treatment (2017-2022). Spine, 51(14), 1002. https://doi.org/10.1097/BRS.0000000000005723

Chicago Style (17th ed.) Citation

BM, Striano, et al. "Revisiting Survival in the Treatment of Spinal Metastases From Lung Cancer in the Modern Era of Immunotherapy and Molecular Targeted Treatment (2017-2022)." Spine 51, no. 14 (2026): 1002. https://doi.org/10.1097/BRS.0000000000005723.

MLA (9th ed.) Citation

BM, Striano, et al. "Revisiting Survival in the Treatment of Spinal Metastases From Lung Cancer in the Modern Era of Immunotherapy and Molecular Targeted Treatment (2017-2022)." Spine, vol. 51, no. 14, 2026, p. 1002, https://doi.org/10.1097/BRS.0000000000005723.